Sunday, October 21, 2018
- 9:00AM-11:00AM
-
Abstract Number: 289
Adherence of Etanercept in Iraqi Patients with Rheumatoid Arthritis: One- and Five-Year Data from a Local Registry
Health Services Research Poster I – ACR/ARHP- 9:00AM-11:00AM
-
Abstract Number: 55
Adipose Derived Stem Cell Suppressed Synovial Inflammation and Repaired Cartilage Destruction in Rheumatoid Arthritis Model Mice
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 475
Adolescents’ Perspectives on Living with Childhood-Onset Systemic Lupus Erythematosus
Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis- 9:00AM-11:00AM
-
Abstract Number: 733
Advanced Chronic Kidney Disease in Lupus Nephritis: Factors Leading to Progression
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 590
Advances in Therapeutic Management with First Biological Therapy in Rheumatoid Arthritis throughout 15 Years
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 269
Adverse Event Reporting Rates and Placebo/Standard-of-Care-Arm American College of Rheumatology Responses Vary By Region in Rheumatoid Arthritis Trials
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 86
Age Dependent Effects of Cholesterol and Smoking on the Risk of Rheumatoid Arthritis in Women – Results from a Nested Case Control Study
Rheumatoid Arthritis – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 492
All Site Cancers and Lymphoma Incidence in US Veterans with Rheumatoid Arthritis 2001-2015
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 39
Allogeneic Mesenchymal Stem Cells Derived Extracellular Vesicles As a Superior Immunosuppressant in Murine Arthritis Therapy
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 136
Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Disease in Multiple Mouse Models of Autoimmunity
T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 72
Altered Serologic Responses to Epstein Barr Virus Precede Clinical Disease Development in Rheumatoid Arthritis
Rheumatoid Arthritis – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 710
An Analysis of Cell-of-Origin in Diffuse Large B-Cell Lymphoma in Systemic Lupus Erythematosus, Including Molecular and Clinical Factors Associated with Survival
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 576
An Analysis of Early Introduction of Adalimumab and Subsequent Bio-Free Condition in the Patients with Rheumatoid Arthritis